whole-brain radiation therapy
Sponsors
Vanderbilt-Ingram Cancer Center, National Cancer Institute (NCI), National Cancer Center, Korea, Rutgers, The State University of New Jersey, Cancer Trials Ireland
Conditions
Cognitive/Functional EffectsLeukemiaLung CancerMale Breast CancerMetastatic CancerNeurotoxicityRadiation ToxicityStage IV Breast Cancer
Phase 1
Everolimus and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastasis From Non-Small Cell Lung Cancer
TerminatedNCT00892801
Start: 2009-05-31End: 2011-02-28Updated: 2012-03-12
Cediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer
TerminatedNCT00937482
Start: 2009-08-31Updated: 2013-03-08
Riluzole and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
TerminatedNCT01018836
Start: 2009-11-30End: 2013-12-31Updated: 2014-05-02
Phase 2
Phase 3
Radiation Therapy to the Brain or Observation in Preventing Brain Metastases in Patients With Advanced Non-Small Cell Lung Cancer
NCT00955695
Start: 2009-05-31Target: 242Updated: 2013-08-02
Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases That Have Been Removed By Surgery
CompletedNCT01372774
Start: 2011-07-31End: 2019-12-15Updated: 2022-09-16
Unknown Phase
Palliative 3-Dimensional Conformal Radiation Therapy in Reducing Radiation Side Effects in Patients With Lung Cancer. ICORG 06-34
CompletedNCT01176487
Start: 2010-06-30End: 2016-03-31Target: 40Updated: 2016-03-31
Voxel Based Diffusion Tensor Imaging in Predicting Response in Patients With Brain Metastases Undergoing Whole Brain Radiation Therapy or Stereotactic Radiosurgery
WithdrawnNCT02277561
Start: 2013-04-30End: 2014-12-31Updated: 2020-03-04